| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 668.52M | 671.18M | 650.51M | 587.76M | 398.28M |
| Gross Profit | 668.52M | 671.18M | 558.29M | 569.59M | 382.58M |
| EBITDA | 139.40M | 116.24M | 77.58M | 23.61M | -6.26M |
| Net Income | 52.22M | 45.07M | 32.36M | -43.34M | -65.87M |
Balance Sheet | |||||
| Total Assets | 1.18B | 1.16B | 1.15B | 1.07B | 1.08B |
| Cash, Cash Equivalents and Short-Term Investments | 87.25M | 78.64M | 93.90M | 35.93M | 45.93M |
| Total Debt | 381.30M | 379.33M | 380.64M | 385.70M | 424.26M |
| Total Liabilities | 929.05M | 911.83M | 880.44M | 837.63M | 802.61M |
| Stockholders Equity | 247.92M | 250.25M | 274.53M | 236.30M | 272.52M |
Cash Flow | |||||
| Free Cash Flow | 112.40M | 91.03M | 89.73M | 64.37M | 92.22M |
| Operating Cash Flow | 175.11M | 146.41M | 138.88M | 102.53M | 119.15M |
| Investing Cash Flow | -61.83M | -55.55M | -48.80M | -38.15M | -26.92M |
| Financing Cash Flow | -107.41M | -105.61M | -31.05M | -67.74M | -50.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €499.92M | 9.21 | 20.92% | ― | -0.40% | 20.61% | |
70 Outperform | €40.56B | 18.70 | 24.42% | 4.09% | 10.03% | 9.63% | |
69 Neutral | €2.69B | 16.50 | 18.84% | 1.84% | 3.22% | 20.93% | |
68 Neutral | €22.55B | 16.60 | 26.71% | 2.24% | 4.61% | 3.06% | |
61 Neutral | €12.87B | 14.25 | 9.77% | 3.56% | 3.72% | 17.21% | |
58 Neutral | €43.50B | 49.15 | 15.04% | 1.42% | 5.25% | -72.42% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |